Study of the Safety and Efficacy of a Caffeine-based Antifibrosis Cream in Patients With Breast Cancer Undergoing Radiation Therapy

NCT03768492 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Carcinoma Breast

Interventions

DRUG: Caffeine anhydrous 5% added to Lipoderm Cream Base.
OTHER: Lipoderm Cream Base

Sponsor

NYU Langone Health